SB
Publications
22
Views
13,687
Downloads
3,464
Supervised works
0
Items per page
1 - 22 of 22
Title Published in Access level OA Policy Year Views Downloads
A Systematic Review and Meta-Analysis of HCV ClearanceLiver international
accessLevelRestricted
2017 600 1
Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant PopulationsPloS one
accessLevelPublic
2016 526 230
Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantationKidney international
accessLevelPublic
2016 491 555
PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ TransplantClinical infectious diseases
accessLevelRestricted
2015 532 1
Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genesNature communications
accessLevelPublic
2015 577 160
Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ TransplantationThe Journal of infectious diseases
accessLevelRestricted
2015 723 0
IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ TransplantationThe Journal of infectious diseases
accessLevelRestricted
2015 673 2
The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infectionAlimentary pharmacology & therapeutics
accessLevelRestricted
2014 634 0
The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patientsAIDS
accessLevelRestricted
2014 567 0
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genesNature communications
accessLevelPublic
2014 673 1,222
Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma developmentPloS one
accessLevelPublic
2013 703 618
Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinomaJournal of hepatology
accessLevelRestricted
2013 666 0
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance predictionThe Journal of experimental medicine
accessLevelRestricted
2013 568 0
IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4Journal of viral hepatitis
accessLevelRestricted
2013 639 0
IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5Gut
accessLevelRestricted
2012 589 0
Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapyHepatology
accessLevelRestricted
2012 639 0
A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis CPloS one
accessLevelPublic
2012 746 379
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypesHepatology
accessLevelRestricted
2012 654 0
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infectionGastroenterology
accessLevelRestricted
2012 628 0
The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirinJournal of viral hepatitis
accessLevelRestricted
2012 625 0
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis CJournal of hepatology
accessLevelRestricted
2011 602 0
Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphismsPloS one
accessLevelPublic
2011 632 296
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack